Pharmaceutical Excipients Market - Global Forecast to 2021
出 版 商：MarketsandMarkets
出版日期：2016/06/16
頁 數：257頁
文件格式：PDF
價 格：
USD 5,650 (Single-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
USD 6,650 (Multi-User License)
USD 10,000 (Global-User License)
The global pharmaceutical excipients market is projected to grow at a strong CAGR of 6.1% during the forecast period of 2016-2021 to reach USD 8.1 billion by 2021. The market is mainly driven by emergence of new excipients for the pharmaceutical industry, growing generic drugs market, developments in nanotechnology, and growing global pharmaceutical market. Emerging markets such as India and China and the increasing demand for multi-functionality excipients will provide growth opportunities for major players in the market.
In this report, the global pharmaceutical excipients market is segmented by product, by delivery mode, by functionality, and by region. The pharmaceutical excipients market is classified by product into inorganic chemicals, organic chemicals, and other chemicals. Organic chemicals are further divided into carbohydrates, petrochemicals, oleochemicals, proteins, and others. On the basis of delivery mode, the market is further subsegmented into oral formulations, topical formulations, parenteral formulations, and advanced delivery systems. Oral formulations, by delivery mode, include tablets, capsules, and liquid formulations. By functionality, the pharmaceutical excipients market is divided into fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, and preservatives.
The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market, by functionality, in 2015 and is expected to continue to dominate the market in 2021. However, the lubricant & glidants segment will witness the highest growth. From the manufacturer’s perspective, fillers and diluents offer stability, ease in preparation, packaging, shipping, and dispensing; for patients, they improve the taste of the formulation and provide ease of administration (of the drug). The fillers and diluents market is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs.
Europe dominated the global pharmaceutical excipients market in 2015, followed by North America. Developed geographies like Europe and North America and are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The rapid growth in the Asia-Pacific region is largely driven by the growth in research activities and emerging market for pharmaceutical manufacturing.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), the Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).
Reasons to Buy the Report
The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolios offered by the top players in the pharmaceutical excipients market. The report analyzes the pharmaceutical excipients market by technology, products, and end user across all regions.
‧ Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the pharmaceutical excipients market.
‧ Market Development: Comprehensive information on lucrative emerging markets.
‧ Market Diversification: Exhaustive information on new products, growing regions, recent developments, and investments in the pharmaceutical excipients market.
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the pharmaceutical excipients market.
In this report, the global pharmaceutical excipients market is segmented by product, by delivery mode, by functionality, and by region. The pharmaceutical excipients market is classified by product into inorganic chemicals, organic chemicals, and other chemicals. Organic chemicals are further divided into carbohydrates, petrochemicals, oleochemicals, proteins, and others. On the basis of delivery mode, the market is further subsegmented into oral formulations, topical formulations, parenteral formulations, and advanced delivery systems. Oral formulations, by delivery mode, include tablets, capsules, and liquid formulations. By functionality, the pharmaceutical excipients market is divided into fillers & diluents, binders, suspension & viscosity agents, coatings, flavoring agents, disintegrants, colorants, lubricants & glidants, and preservatives.
The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market, by functionality, in 2015 and is expected to continue to dominate the market in 2021. However, the lubricant & glidants segment will witness the highest growth. From the manufacturer’s perspective, fillers and diluents offer stability, ease in preparation, packaging, shipping, and dispensing; for patients, they improve the taste of the formulation and provide ease of administration (of the drug). The fillers and diluents market is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs.
Europe dominated the global pharmaceutical excipients market in 2015, followed by North America. Developed geographies like Europe and North America and are likely to grow at a lower CAGR as compared to the Asia-Pacific market. The rapid growth in the Asia-Pacific region is largely driven by the growth in research activities and emerging market for pharmaceutical manufacturing.
The major players in the pharmaceutical excipients market include Ashland, Inc. (U.S.), BASF SE (Germany), the Dow Chemical Company (U.S.), Roquette (France), FMC Corporation (U.S.), Evonik Industries AG (Germany), Associated British Foods Plc. (U.K.), Archer Daniels Midland Company (U.S.), Lubrizol Corporation (U.S.), and Croda International Plc. (U.K.).
Reasons to Buy the Report
The report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping a greater market share.
This report provides insights on the following pointers:
‧ Market Penetration: Comprehensive information on product portfolios offered by the top players in the pharmaceutical excipients market. The report analyzes the pharmaceutical excipients market by technology, products, and end user across all regions.
‧ Product Development/Innovation: Detailed insights on upcoming trends, R&D activities, and new product launches in the pharmaceutical excipients market.
‧ Market Development: Comprehensive information on lucrative emerging markets.
‧ Market Diversification: Exhaustive information on new products, growing regions, recent developments, and investments in the pharmaceutical excipients market.
‧ Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, and manufacturing capabilities of leading players in the pharmaceutical excipients market.
TABLE OF CONTENTS
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.5 SECONDARY SOURCES 29
2.5.1 KEY DATA FROM SECONDARY SOURCES 29
2.6 PRIMARY SOURCES 30
2.6.1 KEY DATA FROM PRIMARY SOURCES 30
2.6.2 KEY INDUSTRY INSIGHTS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 37
4.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW 37
4.2 APAC PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 38
4.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC MIX 40
4.4 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Growth of the global pharmaceuticals market backed by functional excipients 43
5.2.1.2 Patent cliffs driving the growth of excipients in the generics market 44
5.2.1.3 Advances in nanotechnology imparting new functions to pharmaceutical excipients 45
5.2.1.4 Emergence of new excipients for the pharmaceutical industry 45
5.2.2 RESTRAINTS 45
5.2.2.1 Declining R&D investments 46
5.2.2.2 Increased regulatory requirements leading to shortage of FDA-approved manufacturing sites 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries 47
5.2.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments 47
5.2.4 CHALLENGES 48
5.2.4.1 Quality concerns 48
6 INDUSTRY INSIGHTS 49
6.1 INDUSTRY TRENDS 49
6.1.1 REGULATORY TRANSITION DRIVEN BY RISING NEED OF HIGH-QUALITY EXCIPIENTS 50
6.1.2 RISING DEMAND FOR NEW EXCIPIENTS AND EMPHASIS ON CO-PROCESSED EXCIPIENTS 51
6.1.3 GROWING NEED IN DIRECT COMPRESSION TO DRIVE DEMAND FOR EXCIPIENTS 51
6.2 PORTER’S FIVE FORCES ANALYSIS 53
6.2.1 THREAT OF NEW ENTRANTS 54
6.2.2 THREAT OF SUBSTITUTES 54
6.2.3 BARGAINING POWER OF SUPPLIERS 54
6.2.4 BARGAINING POWER OF BUYERS 55
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.3 REGULATORY ANALYSIS 56
6.3.1 NORTH AMERICA 56
6.3.1.1 U.S. 56
6.3.1.2 Canada 57
6.3.2 EUROPE 57
6.3.3 APAC 58
6.3.3.1 Japan 58
6.3.3.2 China 58
6.3.3.3 India 59
7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 60
7.1 INTRODUCTION 61
7.2 ORGANIC CHEMICALS 63
7.2.1 OLEOCHEMICALS 65
7.2.1.1 Fatty Alcohols 67
7.2.1.2 Mineral Stearates 68
7.2.1.3 Glycerin 69
7.2.1.4 Other Oleochemical Excipients 70
7.2.2 CARBOHYDRATES 71
7.2.2.1 Sugars 72
7.2.2.2 Actual Sugars 74
7.2.2.2.1 Lactose 75
7.2.2.2.2 Sucrose 76
7.2.2.2.3 Dextrose (D-Glucose) 76
7.2.2.3 Sugar alcohols 76
7.2.2.3.1 Sorbitol 77
7.2.2.3.2 Mannitol 78
7.2.2.3.3 Other sugar alcohols 78
7.2.2.4 Artificial Sweeteners 78
7.2.2.5 Cellulose 79
7.2.2.5.1 Microcrystalline Cellulose 81
7.2.2.5.2 Cellulose Ethers 81
7.2.2.5.3 CMC and Croscarmellose Sodium 83
7.2.2.5.4 Cellulose Esters 84
7.2.2.6 Starch 85
7.2.2.6.1 Modified Starch 87
7.2.2.6.2 Dried Starch 88
7.2.2.6.3 Converted Starch 89
7.2.3 PETROCHEMICALS 90
7.2.3.1 Glycols 91
7.2.3.1.1 Polyethylene Glycol 93
7.2.3.1.2 Propylene Glycol 93
7.2.3.2 Povidones 93
7.2.3.3 Mineral Hydrocarbons 94
7.2.3.3.1 Petrolatum 95
7.2.3.3.2 Mineral Waxes 95
7.2.3.3.3 Mineral Oils 96
7.2.3.4 Acrylic Polymers 96
7.2.3.5 Other Petrochemical Excipients 97
7.2.4 PROTEINS 98
7.2.5 OTHER ORGANIC CHEMICALS 99
7.3 INORGANIC CHEMICALS 100
7.3.1 CALCIUM PHOSPHATES 102
7.3.2 METAL OXIDES 103
7.3.3 HALITES 104
7.3.4 CALCIUM CARBONATES 105
7.3.5 CALCIUM SULFATES 106
7.3.6 OTHER INORGANIC CHEMICALS 107
7.4 OTHER CHEMICALS 108
8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 109
8.1 INTRODUCTION 110
8.2 FILLERS & DILUENTS 111
8.3 BINDERS 113
8.4 SUSPENSION & VISCOSITY AGENTS 114
8.5 COATINGS 115
8.6 DISINTEGRANTS 116
8.7 FLAVORING AGENTS 117
8.8 LUBRICANTS & GLIDANTS 118
8.9 COLORANTS 119
8.10 PRESERVATIVES 120
8.11 OTHER FUNCTIONALITIES 121
9 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION 122
9.1 INTRODUCTION 123
9.2 ORAL FORMULATIONS 124
9.2.1 TABLETS 126
9.2.2 CAPSULES 127
9.2.2.1 Hard Gelatin Capsules 129
9.2.2.2 Soft Gelatin Capsules 130
9.2.3 LIQUID FORMULATIONS 132
9.3 TOPICAL FORMULATIONS 134
9.4 PARENTERAL FORMULATIONS 136
9.5 ADVANCED DELIVERY SYSTEMS 138
10 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION 140
10.1 INTRODUCTION 141
10.2 EUROPE 143
10.2.1 SWITZERLAND 148
10.2.2 GERMANY 150
10.2.3 ITALY 153
10.2.4 FRANCE 156
10.2.5 U.K. 159
10.2.6 SPAIN 162
10.2.7 REST OF EUROPE (ROE) 165
10.3 NORTH AMERICA 168
10.3.1 U.S. 171
10.3.2 CANADA 174
10.4 ASIA-PACIFIC (APAC) 178
10.4.1 JAPAN 182
10.4.2 CHINA 185
10.4.3 INDIA 188
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 191
10.5 REST OF THE WORLD (ROW) 194
10.5.1 LATIN AMERICA 197
10.5.2 MIDDLE EAST AND AFRICA 200
11 COMPETITIVE LANDSCAPE 203
11.1 INTRODUCTION 203
11.2 MARKET SHARE ANALYSIS 205
11.2.1 MARKET SHARE ANALYSIS: GLOBAL 205
11.2.2 MARKET SHARE ANALYSIS: NORTH AMERICA 206
11.2.3 MARKET SHARE ANALYSIS: EUROPE 207
11.2.4 MARKET SHARE ANALYSIS: APAC 208
11.3 COMPETITIVE SITUATION AND TRENDS 209
11.3.1 EXPANSIONS 210
11.3.2 PRODUCT LAUNCHES 211
11.3.3 AGREEMENTS, ALLIANCES, AND COLLABORATIONS 212
11.3.4 MERGERS AND ACQUISITIONS 213
11.3.5 INTELLECTUAL PROPERTY ACQUISITIONS 214
12 COMPANY PROFILES 215
(Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*
12.1 INTRODUCTION 215
12.2 ASHLAND INC. 216
12.3 BASF SE 219
12.4 THE DOW CHEMICAL COMPANY 222
12.5 FMC CORPORATION 225
12.6 ROQUETTE GROUP 228
12.7 EVONIK INDUSTRIES AG 231
12.8 ASSOCIATED BRITISH FOODS PLC 233
12.9 THE LUBRIZOL CORPORATION 235
12.10 ARCHER DANIELS MIDLAND COMPANY 237
12.11 CRODA INTERNATIONAL PLC 239
*Details on company financial might not be captured in case of unlisted companies
?
13 APPENDIX 242
13.1 INSIGHTS OF INDUSTRY EXPERTS 242
13.2 DISCUSSION GUIDE 243
13.3 OTHER DEVELOPMENTS 248
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
13.5 AVAILABLE CUSTOMIZATIONS 254
13.6 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 254
13.7 RELATED REPORTS 256
1 INTRODUCTION 21
1.1 OBJECTIVES OF THE STUDY 21
1.2 MARKET DEFINITION 21
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 22
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 23
1.5 STAKEHOLDERS 23
2 RESEARCH METHODOLOGY 24
2.1 RESEARCH APPROACH 24
2.2 MARKET SIZE ESTIMATION 26
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 27
2.4 MARKET SHARE ESTIMATION 28
2.5 SECONDARY SOURCES 29
2.5.1 KEY DATA FROM SECONDARY SOURCES 29
2.6 PRIMARY SOURCES 30
2.6.1 KEY DATA FROM PRIMARY SOURCES 30
2.6.2 KEY INDUSTRY INSIGHTS 31
3 EXECUTIVE SUMMARY 32
4 PREMIUM INSIGHTS 37
4.1 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET OVERVIEW 37
4.2 APAC PHARMACEUTICAL EXCIPIENTS MARKET, BY FORMULATION 38
4.3 PHARMACEUTICAL EXCIPIENTS MARKET: GEOGRAPHIC MIX 40
4.4 PHARMACEUTICAL EXCIPIENTS MARKET: DEVELOPING VS. DEVELOPED COUNTRIES/REGIONS 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Growth of the global pharmaceuticals market backed by functional excipients 43
5.2.1.2 Patent cliffs driving the growth of excipients in the generics market 44
5.2.1.3 Advances in nanotechnology imparting new functions to pharmaceutical excipients 45
5.2.1.4 Emergence of new excipients for the pharmaceutical industry 45
5.2.2 RESTRAINTS 45
5.2.2.1 Declining R&D investments 46
5.2.2.2 Increased regulatory requirements leading to shortage of FDA-approved manufacturing sites 46
5.2.3 OPPORTUNITIES 47
5.2.3.1 Shifting focus of pharmaceutical manufacturing to emerging countries 47
5.2.3.2 Multi-functionality excipients are proving to be emerging areas of new product developments 47
5.2.4 CHALLENGES 48
5.2.4.1 Quality concerns 48
6 INDUSTRY INSIGHTS 49
6.1 INDUSTRY TRENDS 49
6.1.1 REGULATORY TRANSITION DRIVEN BY RISING NEED OF HIGH-QUALITY EXCIPIENTS 50
6.1.2 RISING DEMAND FOR NEW EXCIPIENTS AND EMPHASIS ON CO-PROCESSED EXCIPIENTS 51
6.1.3 GROWING NEED IN DIRECT COMPRESSION TO DRIVE DEMAND FOR EXCIPIENTS 51
6.2 PORTER’S FIVE FORCES ANALYSIS 53
6.2.1 THREAT OF NEW ENTRANTS 54
6.2.2 THREAT OF SUBSTITUTES 54
6.2.3 BARGAINING POWER OF SUPPLIERS 54
6.2.4 BARGAINING POWER OF BUYERS 55
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 55
6.3 REGULATORY ANALYSIS 56
6.3.1 NORTH AMERICA 56
6.3.1.1 U.S. 56
6.3.1.2 Canada 57
6.3.2 EUROPE 57
6.3.3 APAC 58
6.3.3.1 Japan 58
6.3.3.2 China 58
6.3.3.3 India 59
7 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY PRODUCT 60
7.1 INTRODUCTION 61
7.2 ORGANIC CHEMICALS 63
7.2.1 OLEOCHEMICALS 65
7.2.1.1 Fatty Alcohols 67
7.2.1.2 Mineral Stearates 68
7.2.1.3 Glycerin 69
7.2.1.4 Other Oleochemical Excipients 70
7.2.2 CARBOHYDRATES 71
7.2.2.1 Sugars 72
7.2.2.2 Actual Sugars 74
7.2.2.2.1 Lactose 75
7.2.2.2.2 Sucrose 76
7.2.2.2.3 Dextrose (D-Glucose) 76
7.2.2.3 Sugar alcohols 76
7.2.2.3.1 Sorbitol 77
7.2.2.3.2 Mannitol 78
7.2.2.3.3 Other sugar alcohols 78
7.2.2.4 Artificial Sweeteners 78
7.2.2.5 Cellulose 79
7.2.2.5.1 Microcrystalline Cellulose 81
7.2.2.5.2 Cellulose Ethers 81
7.2.2.5.3 CMC and Croscarmellose Sodium 83
7.2.2.5.4 Cellulose Esters 84
7.2.2.6 Starch 85
7.2.2.6.1 Modified Starch 87
7.2.2.6.2 Dried Starch 88
7.2.2.6.3 Converted Starch 89
7.2.3 PETROCHEMICALS 90
7.2.3.1 Glycols 91
7.2.3.1.1 Polyethylene Glycol 93
7.2.3.1.2 Propylene Glycol 93
7.2.3.2 Povidones 93
7.2.3.3 Mineral Hydrocarbons 94
7.2.3.3.1 Petrolatum 95
7.2.3.3.2 Mineral Waxes 95
7.2.3.3.3 Mineral Oils 96
7.2.3.4 Acrylic Polymers 96
7.2.3.5 Other Petrochemical Excipients 97
7.2.4 PROTEINS 98
7.2.5 OTHER ORGANIC CHEMICALS 99
7.3 INORGANIC CHEMICALS 100
7.3.1 CALCIUM PHOSPHATES 102
7.3.2 METAL OXIDES 103
7.3.3 HALITES 104
7.3.4 CALCIUM CARBONATES 105
7.3.5 CALCIUM SULFATES 106
7.3.6 OTHER INORGANIC CHEMICALS 107
7.4 OTHER CHEMICALS 108
8 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY 109
8.1 INTRODUCTION 110
8.2 FILLERS & DILUENTS 111
8.3 BINDERS 113
8.4 SUSPENSION & VISCOSITY AGENTS 114
8.5 COATINGS 115
8.6 DISINTEGRANTS 116
8.7 FLAVORING AGENTS 117
8.8 LUBRICANTS & GLIDANTS 118
8.9 COLORANTS 119
8.10 PRESERVATIVES 120
8.11 OTHER FUNCTIONALITIES 121
9 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY TYPE OF FORMULATION 122
9.1 INTRODUCTION 123
9.2 ORAL FORMULATIONS 124
9.2.1 TABLETS 126
9.2.2 CAPSULES 127
9.2.2.1 Hard Gelatin Capsules 129
9.2.2.2 Soft Gelatin Capsules 130
9.2.3 LIQUID FORMULATIONS 132
9.3 TOPICAL FORMULATIONS 134
9.4 PARENTERAL FORMULATIONS 136
9.5 ADVANCED DELIVERY SYSTEMS 138
10 GLOBAL PHARMACEUTICAL EXCIPIENTS MARKET, BY REGION 140
10.1 INTRODUCTION 141
10.2 EUROPE 143
10.2.1 SWITZERLAND 148
10.2.2 GERMANY 150
10.2.3 ITALY 153
10.2.4 FRANCE 156
10.2.5 U.K. 159
10.2.6 SPAIN 162
10.2.7 REST OF EUROPE (ROE) 165
10.3 NORTH AMERICA 168
10.3.1 U.S. 171
10.3.2 CANADA 174
10.4 ASIA-PACIFIC (APAC) 178
10.4.1 JAPAN 182
10.4.2 CHINA 185
10.4.3 INDIA 188
10.4.4 REST OF ASIA-PACIFIC (ROAPAC) 191
10.5 REST OF THE WORLD (ROW) 194
10.5.1 LATIN AMERICA 197
10.5.2 MIDDLE EAST AND AFRICA 200
11 COMPETITIVE LANDSCAPE 203
11.1 INTRODUCTION 203
11.2 MARKET SHARE ANALYSIS 205
11.2.1 MARKET SHARE ANALYSIS: GLOBAL 205
11.2.2 MARKET SHARE ANALYSIS: NORTH AMERICA 206
11.2.3 MARKET SHARE ANALYSIS: EUROPE 207
11.2.4 MARKET SHARE ANALYSIS: APAC 208
11.3 COMPETITIVE SITUATION AND TRENDS 209
11.3.1 EXPANSIONS 210
11.3.2 PRODUCT LAUNCHES 211
11.3.3 AGREEMENTS, ALLIANCES, AND COLLABORATIONS 212
11.3.4 MERGERS AND ACQUISITIONS 213
11.3.5 INTELLECTUAL PROPERTY ACQUISITIONS 214
12 COMPANY PROFILES 215
(Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*
12.1 INTRODUCTION 215
12.2 ASHLAND INC. 216
12.3 BASF SE 219
12.4 THE DOW CHEMICAL COMPANY 222
12.5 FMC CORPORATION 225
12.6 ROQUETTE GROUP 228
12.7 EVONIK INDUSTRIES AG 231
12.8 ASSOCIATED BRITISH FOODS PLC 233
12.9 THE LUBRIZOL CORPORATION 235
12.10 ARCHER DANIELS MIDLAND COMPANY 237
12.11 CRODA INTERNATIONAL PLC 239
*Details on company financial might not be captured in case of unlisted companies
?
13 APPENDIX 242
13.1 INSIGHTS OF INDUSTRY EXPERTS 242
13.2 DISCUSSION GUIDE 243
13.3 OTHER DEVELOPMENTS 248
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
13.5 AVAILABLE CUSTOMIZATIONS 254
13.6 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 254
13.7 RELATED REPORTS 256
